Capital Research Global Investors - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 919 filers reported holding NOVARTIS A G in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.6%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$92,042,428
+1.0%
903,617
+0.0%
0.02%
+4.2%
Q2 2023$91,146,251
+9.7%
903,243
+0.0%
0.02%0.0%
Q1 2023$83,060,820
-7.0%
902,835
-8.3%
0.02%
-11.1%
Q4 2022$89,305,494
+19.4%
984,4080.0%0.03%
+8.0%
Q3 2022$74,825,000
-10.1%
984,408
-0.0%
0.02%
-3.8%
Q2 2022$83,241,000
-3.7%
984,751
-0.0%
0.03%
+23.8%
Q1 2022$86,444,000
+9.5%
985,114
+9.1%
0.02%
+23.5%
Q4 2021$78,955,000
+6.9%
902,656
-0.0%
0.02%0.0%
Q3 2021$73,851,000
-10.3%
903,040
+0.0%
0.02%
-10.5%
Q2 2021$82,364,000
-59.3%
902,720
-61.8%
0.02%
-61.2%
Q1 2021$202,245,000
-9.4%
2,365,745
+0.1%
0.05%
-15.5%
Q4 2020$223,164,000
+34.5%
2,363,280
+23.9%
0.06%
+16.0%
Q3 2020$165,924,000
+9.2%
1,908,046
+9.6%
0.05%
+4.2%
Q2 2020$152,009,000
+6.1%
1,740,433
+0.1%
0.05%
-14.3%
Q1 2020$143,311,000
-20.9%
1,738,253
-9.1%
0.06%
+3.7%
Q4 2019$181,106,000
+9.2%
1,912,635
+0.2%
0.05%0.0%
Q3 2019$165,878,000
-4.5%
1,908,796
+0.4%
0.05%
-1.8%
Q2 2019$173,681,000
+16.5%
1,902,109
+22.7%
0.06%
+17.0%
Q1 2019$149,025,000
+12.0%
1,550,085
+0.0%
0.05%
+2.2%
Q4 2018$133,013,000
-0.4%
1,550,0840.0%0.05%
+17.9%
Q3 2018$133,555,000
+14.1%
1,550,084
-0.0%
0.04%
+21.9%
Q2 2018$117,094,000
-6.6%
1,550,087
+0.0%
0.03%
-11.1%
Q1 2018$125,319,000
-33.9%
1,550,016
-31.4%
0.04%
-35.7%
Q4 2017$189,625,000
-2.2%
2,258,5150.0%0.06%
-5.1%
Q3 2017$193,894,000
+2.9%
2,258,515
+0.0%
0.06%0.0%
Q2 2017$188,517,000
+12.4%
2,258,5050.0%0.06%
+11.3%
Q1 2017$167,739,000
+2.0%
2,258,505
+0.0%
0.05%0.0%
Q4 2016$164,509,000
-7.8%
2,258,5000.0%0.05%
-10.2%
Q3 2016$178,331,000
-4.3%
2,258,5000.0%0.06%
-7.8%
Q2 2016$186,349,000
+13.9%
2,258,5000.0%0.06%
+14.3%
Q1 2016$163,606,000
-15.8%
2,258,5000.0%0.06%
-15.2%
Q4 2015$194,321,000
-6.4%
2,258,5000.0%0.07%
-10.8%
Q3 2015$207,601,000
-6.5%
2,258,5000.0%0.07%
+1.4%
Q2 2015$222,101,000
-0.3%
2,258,5000.0%0.07%
-3.9%
Q1 2015$222,711,000
-4.4%
2,258,500
-10.2%
0.08%
-3.8%
Q4 2014$233,045,000
-1.6%
2,515,0560.0%0.08%
-3.7%
Q3 2014$236,742,000
+4.0%
2,515,0560.0%0.08%
+2.5%
Q2 2014$227,688,000
+9.0%
2,515,056
+2.4%
0.08%
+6.7%
Q1 2014$208,899,000
+5.8%
2,457,0560.0%0.08%
+2.7%
Q4 2013$197,498,000
+4.8%
2,457,0560.0%0.07%
-1.4%
Q3 2013$188,481,000
+8.5%
2,457,0560.0%0.07%0.0%
Q2 2013$173,738,0002,457,0560.07%
Other shareholders
NOVARTIS A G shareholders Q4 2015
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders